Clinical trials
Phase 1/2 Lymphoma, Non-Hodgkin trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Unknown status | 8 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Completed | 3 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 7 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 3 |
| AstraZeneca | 2 |
| Essen Biotech | 2 |
| Adagene (Suzhou) Limited | 1 |
| Ascentage Pharma Group Inc. | 1 |
| BeOne Medicines | 1 |
| BeiGene | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Beijing Mabworks Biotech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 41 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Recurrence | 5 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Mantle-Cell | 3 |
| Lymphoma, T-Cell, Peripheral | 3 |
| Hematologic Neoplasms | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.